Cancer
-
Challenge to find treatable cancer mutations
Oncologists face a huge task to identify which of thousands of recently identified genetic mutations in cancer are worth targeting with drug treatments, European experts have warned. Read more
-
New drug class unveiled at Imperial
British researchers have announced the development of a new class of drug developed to treat drug-resistant tumours. Read more
-
How important is weight loss as cancer indicator?
Unexplained weight loss is a hugely significant predictor of cancer risk, researchers say today. Read more
-
Call for improved prostate testing as cancer cases missed
Urgent action is needed to find an effective way of screening for prostate cancer, campaigners and specialists say today. Read more
-
Patient gets printed rib
For the first time in the UK, a “printed” prosthetic rib has been transplanted into a patient during surgery, it has been announced. Read more
-
Men should be involved in breast cancer trials
A leading oncologist has called for men to be included in breast cancer trials to help improve treatments for the disease. Read more
-
Targeted drugs beneficial to HER2 positive patients
Women with HER2 positive breast cancer could avoid having extensive surgery involving mastectomy and removal of several lymph nodes by receiving targeted drugs before surgery, leading oncologists have heard. Read more
-
Concern as breast tumour detection progress stalls
Progress in detecting breast tumours at an early stage may have stalled this century, a European conference will hear today. Read more
-
Improved breast cancer relapse test unveiled
Breast cancer patients with the BRCA mutation and an increased risk of relapse can be identified by testing for other genetic variants, a European conference will hear today. Read more
-
Colorectal cancer mortality rates falling – European analysis
Europe has achieved major progress in reducing mortality from colorectal cancer, experts say today. Read more
